The annual death rate for lung cancer is higher than cervical, prostate, colon and breast cancers combined, yet screening for those cancers is widely accepted and screening for lung cancer is not. A recent study by Dr. James Mulshine and researchers at the Rush University Medical Center, published in the April 2012 issue of Health Affairs, found that low-dose spiral CT screening would greatly reduce lung cancer mortality and cost less than other standard cancer screenings.
Since spiral CT can detect early-stage lung cancer, cancer-related death could be reduced 20 percent if people at high risk received three annual screenings. Catching cancer in its early stages would result in earlier and lower treatment costs as well as a lower mortality rate.
Read the full News-Medical.net article.